Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000175994 | SCV000227574 | benign | not specified | 2015-02-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000175994 | SCV000316377 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000297070 | SCV000450134 | likely benign | Ellis-van Creveld syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Center for Pediatric Genomic Medicine, |
RCV000427833 | SCV000511709 | likely benign | not provided | 2017-02-13 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Labcorp Genetics |
RCV001083424 | SCV000634724 | benign | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000175994 | SCV000728827 | benign | not specified | 2018-01-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ce |
RCV000427833 | SCV001154154 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | EVC: BP4, BS2 |
ARUP Laboratories, |
RCV000427833 | SCV001157161 | benign | not provided | 2023-10-09 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000297070 | SCV001653480 | likely benign | Ellis-van Creveld syndrome | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000175994 | SCV002064889 | benign | not specified | 2018-02-28 | criteria provided, single submitter | clinical testing | |
Sydney Genome Diagnostics, |
RCV001328200 | SCV001449318 | uncertain significance | Nephronophthisis | 2018-10-25 | no assertion criteria provided | clinical testing | This patient is heterozygous for a variant of unknown clinical significance (VOUS), c.284A>G p.(Asp95Gly) in the EVC gene. To our knowledge, this variant has not been previously reported in the literature. However, this variant has been reported in dbSNP (rs4126957) with a minor allele frequency (MAF) of 0.0067 in the European American population (n=8600). In silico analysis (Alamut Visual v2.4) is inconclusive regarding this variant, Align GVGD, MutationTaster and KD4v predicts it to be benign whereas PolyPhen2 and SIFT predicts it to be pathogenic. Alamut v2.4 also predicts this variant does not affect splicing. |
Laboratory of Diagnostic Genome Analysis, |
RCV000175994 | SCV001800721 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000175994 | SCV001927123 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000427833 | SCV001969356 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000297070 | SCV002083012 | likely benign | Ellis-van Creveld syndrome | 2019-12-04 | no assertion criteria provided | clinical testing |